However, the inhibitory effect of paquinimod may be incomplete in terms of S100A9 inhibition; S100A9-knockout mice had a more severe disease than C57BL/6 controls in experimental autoimmune encephalomyelitis, but they still responded to treatment with paquinimod [29]. The gene discussed is S100A9; the disease is experimental autoimmune encephalomyelitis.